← All indications
Rhinitis, Allergic, Perennial
Inflammation of the mucous membrane of the nose similar to that found in hay fever except that symptoms persist throughout the year. The causes are usually air-borne allergens, particularly dusts, feathers, molds, animal fur, etc.
Subtype terms (1)
More specific conditions that are subtypes of Rhinitis, Allergic, Perennial in the MeSH hierarchy.
Drugs by status
Approved for this indication (15)
Phase 4 trials (5)
Phase 3 trials (28)
- urea
- ketotifen
- pranlukast
- prednisone
- betamethasone
- epinastine
- ewo1
- flunisolide
- timothy grass pollen allergen extract
- iloperidone
- lorazepam
- ephedrine
- lebrikizumab
- levocabastine
- paeonia lactiflora
- bilastine
- epinephrine
- bepotastine
- ketoconazole
- pinellia
- glycyrrhiza
- schisandra chinensis
- pseudoephedrine
- lactobacillus casei
- cinnamomum cassia
- Zingiber officinale
- asiasarum sieboldi f. maekawa
- alk alutard 5-grasses
Phase 2 trials (6)
Phase 1 trials (4)
Organizations
Organization Involved with Phase 4 Indications (13)
Organization Involved with Phase 3 Indications (38)
- Meda
- Stallergenes
- Biomedical Development Corporation
- Eurofarma Laboratorios S.A.
- Faes Farma, S.A.
- Hanlim Pharm. Co., Ltd.
- SamA Pharmaceutical Co., Ltd
- Teva
- Ahn-Gook Pharmaceuticals Co.,Ltd
- Boehringer Ingelheim
- Chong Kun Dang Pharmaceutical
- GenMont Biotech Incorporation
- Hanyang University
- Kyung Hee University
- Medical University of Lodz
- Seoul National University
- University of South Florida
- Yonsei University
- University of Ulsan
- Glenmark Pharmaceuticals
- Allergisa Pesquisa Dermato-Cosmetica LTDA
- Azidus
- Hanmi Pharmaceutical
- University of Montpellier
- Konkuk University
- Nippon Medical School
- Catholic University of Korea
- Mitsubishi Tanabe
- EMS S/A
- LAL Clinical Reseach e Development Ltda
- +8 more
Organization Involved with Phase 2 Indications (7)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (3)